THE THROGMORTON TRUST PLC
All information is at 30 September 2010 and unaudited.
Performance at month end is calculated on a cum income basis
One Three One Three
Month Months Year Years
Net asset value# 14.3% 27.1% 42.9% 8.5%
Net asset value^ 14.3% 27.1% 42.9% 3.5%
Net asset value^^ 11.8% 21.7% 35.4% -1.9%
Share price 8.4% 14.6% 31.1% -1.9%
Subscription share price 63.6% 81.2% n/a n/a
HGSC plus AIM (ex Inv Cos) 8.8% 14.1% 17.7% -7.4%
# NAV prior to costs of repaying the debentures early
^ NAV after costs of repaying the debentures early - undiluted
^^ NAV after costs of repaying debentures early - diluted
Sources: BlackRock and Datastream
At month end
Net asset value capital only: 195.31p
Net asset value incl. income: 197.62p
Share price: 151.50p
Discount to capital only NAV: 22.4%
Subscription share price: 13.50p
Net yield: 1.8% *
Total assets: £121.5m **
Gearing: Nil
Ordinary shares in issue: 58,367,192 ***
Subscription shares in issue: 14,763,134
*Calculated using prior year interim and final dividends paid.
**Includes current year revenue.
***Excluding 7,400,000 shares held in treasury.
Ten Largest Sector
Weightings % of Total Assets
Software & Computer Services 11.0
Mining 10.0
Oil & Gas Producers 9.8
Electronic & Electrical Equipment 9.2
Financial Services 7.3
Support Services 7.2
Industrial Engineering 7.0
Media 4.9
Technology Hardware & Equipment 4.4
Pharmaceutical & Biotechnology 4.4
----
Total 75.2
====
Ten Largest Equity Investments (in alphabetical order)~
Company
Abcam
Aveva Group
City of London Investment Group
Domino Printing Sciences
Fidessa
Hutchison China Meditech
Rotork
Spirax-Sarco Engineering
Victrex
Western Coal
Commenting on the markets, Mike Prentis and Richard Plackett, representing the
Investment Manager noted:
September was a very strong month for equities as markets took the view that a
double dip recession was increasingly unlikely. During September the Company's
NAV per share rose by 14.3% on a cum income basis; this was substantially ahead
of the benchmark which rose by 8.8%. The FTSE 100 Index rose by 6.2%.
Our outperformance was derived from stock selection and asset allocation in the
long only portfolio, and continued positive contributions from the CFD
portfolio.
From a stock point of view our relative outperformance was driven by a wide
range of stocks; Western Coal, Encore Oil, IQE, Oxford Instruments, Avocet
Mining and Eastern Platinum in the long only portfolio each contributed more
than 0.25% to relative outperformance.
Western Coal increased production guidance in early October and arranged an
analyst visit; the share price rose ahead of the visit in expectation of good
news. Having drilled the Catcher well in the North Sea and discovered light
oil, which increasingly appears to be one of the largest oil discoveries in the
North Sea in recent years, Encore Oil also drilled an appraisal well on the
Cladhan prospect; this too was successful. Compound semiconductor wafer
manufacturer IQE made a small acquisition and confirmed it was trading well.
Oxford Instruments AGM statement indicated sustained strengthening of demand in
its industrial division; consequently its house broker increased current year
earnings estimates by 33%. Avocet benefitted from rises in the gold price and a
16% increase in its resource base at its Inata mine. Eastern Platinum
benefitted from the recovery in the platinum price.
Pleasingly, there were no poor individual stock relative performances, in that
no one stock contributed more than -0.25% to relative performance.
From a sector point of view, our overweight positions in the mining and
electronic and electrical sectors served us well. Unsurprisingly during a
strong month for markets, our underweight position in food producers also
contributed well.
We sold holdings in two retailers, Halfords and Mothercare. Halfords had
experienced problems with a new distribution centre; Mothercare has been seeing
softer UK trading, and we took the view that the premium rating was likely to
slip. We also sold our holding in Chaucer, a Lloyds insurer. Pricing trends are
not favouring these companies at present.
We bought new holdings in BlueBay Asset Management and Elementis. BlueBay is a
leading specialist manager of fixed income credit. Net fund inflows have been
good and the opportunity in emerging market bonds, among others, looks
attractive. Elementis is a global manufacturer of additives that enhance the
feel, flow and finish of everyday products. Its trading has strengthened
materially, it has good growth opportunities and the valuation remains
attractive.
Latest information is available by typing www.blackrock.co.uk/its on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal).
14 October 2010
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.